Member Info for aj242

LOL, this reminds me so much of the phase 2 results. People have made up their own dates in their mind, the RNS doesn't land, the SP dips and the same muppets are talking about delays into Spring!!! Its genuinely hilarious.

Excellent buying opp for anyone that hasnt loaded up, happened before phase 2 and its just about to happen again.

As always, well said Ghia. If only you posted as much as NDN, this board would be a much better place.

I anticipate a lot of volatility until P3, much like how it was pre-P2 including dips, derampers and the likes, great time to keep buying.

lol- the jacbob rees mogg of LSE like I said- NDN. Ashfield is much more than a PR company ffs! MSL's aren't even allowed to promote and must be reactive in the pre-license setting. Reactive. So the questions come from the clinician. Why would questions arise from clinicians unless the data is positive/EUA approved!

Fair point fruits, I will refrain from continuing this thread.

lol Tommy, I think you need to relax. I hope you all make the most money you can, even more than me. Its not that deep.

Thank you all, having been here for a couple of years, although I don't post too often, I have read everything in some detail and do have faces for you all in my head (however weird that may seem) lol. I agree, deffo not looking to become a pharma comp, but nonetheless, who knows what the T/O price will be. Could be £8,10,20+

I guess it depends on if they tell us about pre-orders in the RNS pre EUA acceptance.

apologies Doc, I know we have had a few of these threads before. I anticipate phase 3 results to lead to £5, and then EUA submission and acceptance probably a few weeks after where the sky is the limit. And then the orders...

I know we have had posts like this in the past, but I am really struggling to pick a price to sell/derisk. I am one of the numpties that bought at 39p and then sold on the bell at 100p on manic monday only for it to rise to 220p on the day....

major issue for me is I am away from next week for 2 weeks with a 5 hour time difference so I am going to have to set my alarm at 2am everyday and annoy the mrs

I am so so happy with this RNS. Ashfield would LOVE to partner with big pharma, an AZ or a Roche even if there is a 50% chance of success. It means they form relationships with big pharma companies, if successful then great, if not successful then relationships have been established. However, for little old SNG to partner with them, there has to be a very high chance of success otherwise there isn't a huge benefit for Ashfield.

It is only a matter of time.

Really really silly quesiton, but can someone explain the OSCI scale to me, is it standardised and used frequently in resp studies?

you don't just get sent data on the day and then create an RNS- you have the data for several weeks before an announcement where you analyse the results thoroughly. They 1000000% know the topline results. Simple as that.

NDN is the Jacob Rees Mogg of LSE- someone who speaks with utmost confidence, blinding people into belief. The team will 100% know the topline numbers and the biostatisticians will be working on the whole data package alongside the clinical scientists.

HR's commonly used in oncology studies when determining % reduction in risk of death for OS or % reduction in risk of progression for PFS i.e. and OS with aHR of 0.7 is a 30% reduction in risk of death etc..

Look at the sea of blue, the price is quite obviously being held for an II. Can see us finishing back at 210 by tomorrow EOB

totally agree, i mentioned on twitter yday I expect to see the same pattern to p2 results. A dip followed by a stratospheric rise.

is she actually from the fund, or just another person behind an alias on a public BB lol

what actually happened yday?